New rules designed to kill OTC market, says European regulator

A new Ice Age for OTC derivatives?

Rule-makers have developed new derivatives regulation with the intention of killing off the over-the-counter derivatives market in its current form, according to Giuseppe Insalaco, senior adviser on clearing and settlement regulation at the Central Bank of Ireland.

Speaking during a panel discussion at Risk's OTC Derivatives Clearing Summit Europe in London earlier this week, Insalaco was asked by a fellow panellist whether the reforms had been designed specifically to kill off the OTC market.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options

If you already have an account, please sign in here.


Want to know what’s included in our free membership? Click here

This address will be used to create your account

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: